Genetic association study of glucocerebrosidase gene L444P mutation in essential tremor and multiple system atrophy in mainland China

Abstract The glucocerebrosidase (GBA) gene mutation is emerging as an important risk factor for Parkinson’s disease. We previously reported that the GBA gene L444P mutation is an important risk factor for PD in the Chinese population. The prevalence of this mutation in other neurodegenerative diseas...

Full description

Saved in:
Bibliographic Details
Published in:Journal of clinical neuroscience 2013-02, Vol.20 (2), p.217-219
Main Authors: Sun, Qi-ying, Guo, Ji-feng, Han, Wei-wei, Zuo, Xing, Wang, Lei, Yao, Ling-yan, Pan, Qian, Xia, Kun, Yan, Xin-xiang, Tang, Bei-sha
Format: Article
Language:English
Subjects:
Adolescent
Adult
Aged
Amino Acid Substitution - genetics
Asian Continental Ancestry Group - genetics
China - epidemiology
Essential tremor
Essential Tremor - enzymology
Essential Tremor - epidemiology
Essential Tremor - genetics
Female
Genetic Association Studies - methods
Glucocerebrosidase
Glucosylceramidase - genetics
Humans
L444P
Male
Middle Aged
Multiple system atrophy
Multiple System Atrophy - enzymology
Multiple System Atrophy - epidemiology
Multiple System Atrophy - genetics
Mutation
Neurology
Young Adult
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Abstract The glucocerebrosidase (GBA) gene mutation is emerging as an important risk factor for Parkinson’s disease. We previously reported that the GBA gene L444P mutation is an important risk factor for PD in the Chinese population. The prevalence of this mutation in other neurodegenerative diseases and movement disorders remains completely unexplored in mainland China. In the present study, we extended the screening of GBA gene L444P mutation to Chinese patients with essential tremor (ET) and multiple system atrophy (MSA). We searched for the GBA gene L444P mutation in 109 patients with ET, 54 patients with MSA, and 657 controls from mainland China. None of the 109 patients with ET or 54 patients with MSA carried the GBA gene L444P mutation. Among the 657 controls, we found one L444P heterozygote. The difference in mutation frequencies between patients with ET or MSA and the control group was not statistically significant (chi-squared test, p = 1, respectively). The results suggest that the GBA gene L444P mutation may be not responsible for ET in mainland China. Whether the GBA gene L444P mutation modifies the risk for MSA deserves further study in larger samples.
ISSN:0967-5868
1532-2653
DOI:10.1016/j.jocn.2012.01.055